ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 82 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,000 | -71.8% | 25,100 | -56.3% | 0.00% | -80.0% |
| Q4 2015 | $39,000 | -54.1% | 57,500 | -35.1% | 0.01% | -54.5% |
| Q3 2015 | $85,000 | -80.3% | 88,600 | -75.6% | 0.01% | -81.7% |
| Q2 2015 | $431,000 | +109.2% | 362,800 | +82.6% | 0.06% | +106.9% |
| Q1 2015 | $206,000 | -9.6% | 198,700 | -6.8% | 0.03% | -23.7% |
| Q4 2014 | $228,000 | -18.0% | 213,200 | -16.4% | 0.04% | -9.5% |
| Q3 2014 | $278,000 | +35.0% | 255,100 | +29.8% | 0.04% | +35.5% |
| Q2 2014 | $206,000 | +5.6% | 196,500 | +2.7% | 0.03% | +3.3% |
| Q1 2014 | $195,000 | +53.5% | 191,400 | +73.8% | 0.03% | +36.4% |
| Q4 2013 | $127,000 | -41.5% | 110,100 | -14.9% | 0.02% | -56.0% |
| Q3 2013 | $217,000 | -18.7% | 129,400 | -7.4% | 0.05% | -29.6% |
| Q2 2013 | $267,000 | – | 139,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|